Q2-Header_1280x350_5

Anatomic Pathology Laboratory Services

Comprehensive in-house end-to-end anatomic pathology laboratory, adjunct molecular and histology services are designed to meet your clinical trial needs

The healthcare market landscape is quickly changing, and it is necessary to have an anatomic pathology and histology lab partner who can deliver the services you need. A comprehensive anatomic pathology strategy can be a crucial part of clinical and commercial success of your product.

Support for your anatomic pathology needs

With access to commercial clinical laboratories and a full in-house global Anatomic Pathology (AP) service with a foot print in the Americas, Europe, Asia-Pac and China, and a lab operations team who are adept at assay transfer and validation, we have the ability to support your unique study needs. We create customized solutions for every trial, based on tissue and tumor type, staining requirements, and assay need. Download our anatomic pathology services brochure to learn more about our capabilities. 

Histology services – histology is the study of microscopic structure of tissues. We offer a wide range of histology services, from routine procedures to more highly specialized techniques, including tissue fixation, processing, sectioning, staining, immunohistochemistry, and in situ hybridization. All histological methods and procedures were devised to best preserve the cellular detail of a tissue as close to life as possible and our histotechnologists are highly trained.

For specimens received as fresh biopsies, tissue processing is the first step before any downstream histopathology evaluations.

Tissue embedding and sectioning – After the processing cycle, each cassette of tissue is embedded one at a time. Appropriate care is taken for orienting the samples correctly, and the paraffin block is fully formed. We have both manual and automated microtomes for sectioning a block.

Companion Diagnostic experience – Our scientific experts provide you with an optimal path to co-develop your companion diagnostic with clinical development of the therapeutic, regulatory submission and market launch. Our integrated approach is designed so you optimize time to market and commercial success. Learn more about our companion diagnostic capabilities. 

H&E Staining & FISH and IHC services – Hematoxylin & Eosin (H&E) stain is one of the most commonly used stains and is often paired with other common downstream testing like immunohistochemistry (IHC), in-situ hybridization (FISH) and Molecular testing. An IHC test is used to detect the presence or absence and localization of specific proteins by using antibodies. We offer both manual and automated IHC staining on the latest commercial platforms.

Innovation– Our digital pathology solutions promote faster, more collaborative analysis through the use of innovative, leading edge products and services to enable communication of richer efficacy signals faster and more cost-effectively. Learn more about our digital pathology offering.

 

Our services include

Histology services

Histology is the study of microscopic structure of tissues. We offer a wide range of histology services, from routine procedures to more highly specialized techniques, including tissue fixation, processing, sectioning, staining, immunohistochemistry, and in situ hybridization. All histological methods and procedures were devised to best preserve the cellular detail of a tissue as close to life as possible and our histotechnologists are highly trained.
For specimens received as fresh biopsies, tissue processing is the first step before any downstream histopathology evaluations.

Tissue embedding and sectioning

After the processing cycle, each cassette of tissue is embedded one at a time. Appropriate care is taken for orienting the samples correctly, and the paraffin block is fully formed. We have both manual and automated microtomes for sectioning a block.

Companion Diagnostic experience

Our scientific experts provide you with an optimal path to co-develop your companion diagnostic with clinical development of the therapeutic, regulatory submission and market launch. Our integrated approach is designed so you optimize time to market and commercial success.

Innovation

Our digital pathology solutions promote faster, more collaborative analysis through the use of innovative, leading edge products and services to enable communication of richer efficacy signals faster and more cost-effectively. Learn more about our digital pathology offering.

Anatomic Pathology Laboratory Services support is provided by >25 expert pathologists

Globally harmonized Anatomic Pathology in-house services

We offer a quality management system that delivers high quality, dependable data for your study. All clinical laboratories across our regions ensure a globally harmonized SOP process that minimizes technical variability in your study. Our expert pathologists, histotechnologists, clinical, and laboratory staff are trained in good documentation practices, with each AP lab containing on-site experts with >20 years’ experience.

In each of our labs, we have a goal of at least 98% achievement of turnaround time (TAT) for each study. Our Anatomic Pathology laboratories also participate in an accuracy-driven external quality assurance program (CAP Proficiency Testing) that supports our goal of achieving global harmonization, standardization and high quality results across the globe for every study.

Anatomic Pathology for biomarker development in oncology clinical trials  – We can provide customized, global laboratory anatomic pathology lab solutions specifically suited for the unique combinations of therapeutic indication and targeted mechanism-of-action driving modern oncology drug development.

PD-L1 and predictive tissue biomarkers - In immuno-oncology, one of the most current assays is the determination of PD-L1 status in multiple different tumor types, and most of the current assays that are available are based on IHC. There are also other tissue biomarkers of interest that are influencing combination therapy. By introduction of multiplex IHC, a little amount of tissue can show multiple large numbers of output of markers, and multiple markers can be run in the same tissue sample, in the same assay by the application of multiplex IHC. We are developing multiplex IHC assays that would better define and have a larger output from multiple markers from a small piece of tissue. We support a lot of tissue-based testing where our pathologists clearly identify and earmark the areas of tumor. These samples can be taken for downstream molecular analysis, or for ctDNAs or other sequencing methodologies where our experienced pathologists are able to assure the quality of the sample.

Industry Trends Our Testing Solutions
Less Invasive Sampling
  • Liquid biopsy: cell free nucleic acids and circulating tumor cells (CTCs)
  • Mutation detection including Next Generation Sequencing
  • Flow cytometry, immunoassays, proteomics
Shift toward molecular methods
  • Next generation sequencing (NGS) replacing FISH panels
  • Gene expression panels replacing multiple IHCs
Ultra-high sensitivity
  • Mutation detection at < 0.01%
  • Single-cell analysis by flow cytometry/molecular platforms
  • Detection of disease and early resistance
Companion Diagnostics
  • Already established for many methods
  • Expanding to genomics/NGS platforms



Experience predicting and assessing a patient’s response to checkpoint inhibitors is an integral function to immuno-oncology drug development. Once a tissue sample is received, central tissue pathology testing is performed, and data can be mined for immuno-oncology characterizations, such as PD-L1 proteins or tumor-infiltrating lymphocytes. We then take those characterizations and apply them to drug studies, such as the creation of predictive tissue biomarkers for patient selection.

Anatomic Pathology lab partner for your success

Q2 Solutions has the breadth and depth of scientific experience and expertise across all major therapeutic areas, which help drug developers effectively gain a competitive advantage – helping ensure your success in clinical trials, regulatory approvals and new product launches.


We’re able to go a step further with our capability to validate, transfer, and employ new assays to meet today’s development opportunities. These abilities add significant value as we develop new assays for your trials.

 

Learn more about our global Anatomic Pathology lab services:

Read our brochure
Component 89 – 49

Related Thought Leaders Insights


Anatomic Pathology brochure

The future of anatomic pathology testing across the market landscape is quickly changing, and you need a partner who can deliver the services you need. Having a comprehensive anatomic pathology...

Anatomic Pathology Services

At Q2 Solutions, we treat each sample as if a life depends on it. We offer global Pathology and Histology services to support scientific requirements of oncology clinical trials. Watch this video...

Anatomic Pathology Lab Services

Anatomic Pathology plays an important role in biomarker selection and companion diagnostics. This episode describes three key challenges in immuno-oncology development related to anatomic pathology....